We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

47 hedge funds and large institutions have $34.7M invested in Enzo Biochem, Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more call options, than puts

Call options by funds: $198K | Put options by funds: $84K

10% less funds holding

Funds holding: 5247 (-5)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

44% less capital invested

Capital invested by funds: $61.7M → $34.7M (-$27M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
47
Holders Change
-5
Holders Change %
-9.62%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
5
Increased
9
Reduced
13
Closed
10
Calls
$198K
Puts
$84K
Net Calls
+$114K
Net Calls Change
+$78K
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
-$48.6K -19,985 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
-$45.3K -18,643 Closed
IA
53
IFG Advisory
Georgia
-$39.5K -16,250 Closed
Baird Financial Group
54
Baird Financial Group
Wisconsin
-$36.5K -15,000 Closed
FIA
55
FNY Investment Advisers
New York
-$26K -11,003 Closed
ASN
56
Advisory Services Network
Georgia
-$1.22K -500 Closed
CHC
57
City Holding Co
West Virginia
-$291 -120 Closed

ENZ Hedge Fund Activity: Q2 2023 in Review

47 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2023, worth a combined $34.7M — down 44% from $61.7M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ENZ and 5 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 9 added.

The largest buyer was Potomac Capital Management, adding an estimated $624K. The largest seller was Mirabella Financial Services, exiting entirely with an estimated $13.6M sold.

  • 47 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2023, down from 52 in Q1 2023.
  • Funds reported $34.7M of Enzo Biochem, Inc. stock for Q2 2023, down 44% quarter-over-quarter.
  • 5 funds opened new Enzo Biochem, Inc. positions in Q2 2023 and 10 closed out, a net change of -5 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2023 was Potomac Capital Management, an estimated $624K added.
  • The largest Enzo Biochem, Inc. seller in Q2 2023 was Mirabella Financial Services, an estimated $13.6M sold.

Based on aggregated 13F filings for Q2 2023.